SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-355540
Filing Date
2012-08-14
Accepted
2012-08-14 16:06:50
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d355613d10q.htm 10-Q 571214
2 SECOND AMENDED AND RESTATED BYLAWS d355613dex31.htm EX-3.1 54948
3 SECTION 302 CEO AND CFO CERTIFICATION d355613dex311.htm EX-31.1 5870
4 SECTION 906 CEO AND CFO CERTIFICATION d355613dex321.htm EX-32.1 3002
  Complete submission text file 0001193125-12-355540.txt   3646081

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxiii-20120630.xml EX-101.INS 415779
6 XBRL TAXONOMY EXTENSION SCHEMA rxiii-20120630.xsd EX-101.SCH 37297
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxiii-20120630_cal.xml EX-101.CAL 37779
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxiii-20120630_def.xml EX-101.DEF 139422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxiii-20120630_lab.xml EX-101.LAB 288882
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxiii-20120630_pre.xml EX-101.PRE 199063
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 800-794-6027
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-177498 | Film No.: 121032856
SIC: 2834 Pharmaceutical Preparations